Skip to main content
Erschienen in: Critical Care 5/2013

01.10.2013 | Letter

Hydroxyethyl starch 130/0.4 or hypertonic saline solution to decrease inflammatory response in hemorrhagic shock?

verfasst von: Pierre Esnault, Bertrand Prunet, Jean Cotte, Pierre-Julien Cungi, Audrey Alonso, Ambroise Montcriol

Erschienen in: Critical Care | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Excerpt

We read with great interest the study by Chen and colleagues highlighting interest in hydroxyethyl starch (HES) 130/0.4 in treatment after hemorrhagic shock to ameliorate oxidative stress and the inflammatory response in a rat model. Compared with HES 200/0.5 and succinylated gelatin, the authors showed that infusions of HES 130/0.4 significantly reduced malondialdehyde levels and myeloperoxidase activity and also inhibited about 50% of TNF-α production in the intestine [1]. …
Literatur
1.
Zurück zum Zitat Chen G, You G, Wang Y, Lu M, Cheng W, Yang J, Zhao L, Zhou H: Effects of synthetic colloids on oxidative stress and inflammatory response in hemorrhagic shock: comparison of hydroxyethyl starch 130/0.4, hydroxyethyl starch 200/0.5, and succinylated gelatin. Crit Care 2013, 17: R141. 10.1186/cc12820PubMedCentralCrossRefPubMed Chen G, You G, Wang Y, Lu M, Cheng W, Yang J, Zhao L, Zhou H: Effects of synthetic colloids on oxidative stress and inflammatory response in hemorrhagic shock: comparison of hydroxyethyl starch 130/0.4, hydroxyethyl starch 200/0.5, and succinylated gelatin. Crit Care 2013, 17: R141. 10.1186/cc12820PubMedCentralCrossRefPubMed
2.
Zurück zum Zitat Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, et al.: Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012, 367: 124-134. 10.1056/NEJMoa1204242CrossRefPubMed Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, et al.: Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012, 367: 124-134. 10.1056/NEJMoa1204242CrossRefPubMed
3.
Zurück zum Zitat Marko N: Hypertonic saline, not mannitol, should be considered gold-standard medical therapy for intracranial hypertension. Crit Care 2012, 16: 113.PubMedCentralPubMed Marko N: Hypertonic saline, not mannitol, should be considered gold-standard medical therapy for intracranial hypertension. Crit Care 2012, 16: 113.PubMedCentralPubMed
4.
Zurück zum Zitat Bahrami S, Zimmermann K, Szelényi Z, Hamar J, Scheiflinger F, Redl H, Junger WG: Small-volume fluid resuscitation with hypertonic saline prevents inflammation but not mortality in a rat model of hemorrhagic shock. Shock 2006, 25: 283-289. 10.1097/01.shk.0000208808.03148.eaCrossRefPubMed Bahrami S, Zimmermann K, Szelényi Z, Hamar J, Scheiflinger F, Redl H, Junger WG: Small-volume fluid resuscitation with hypertonic saline prevents inflammation but not mortality in a rat model of hemorrhagic shock. Shock 2006, 25: 283-289. 10.1097/01.shk.0000208808.03148.eaCrossRefPubMed
5.
Zurück zum Zitat Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M: Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012, 308: 1566-1572. 10.1001/jama.2012.13356CrossRefPubMed Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M: Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012, 308: 1566-1572. 10.1001/jama.2012.13356CrossRefPubMed
Metadaten
Titel
Hydroxyethyl starch 130/0.4 or hypertonic saline solution to decrease inflammatory response in hemorrhagic shock?
verfasst von
Pierre Esnault
Bertrand Prunet
Jean Cotte
Pierre-Julien Cungi
Audrey Alonso
Ambroise Montcriol
Publikationsdatum
01.10.2013
Verlag
BioMed Central
Erschienen in
Critical Care / Ausgabe 5/2013
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc13043

Weitere Artikel der Ausgabe 5/2013

Critical Care 5/2013 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.